STIC Ventures key facts
- STIC Ventures is a venture capital firm based in Seoul, Gangnam-gu with 63 tracked portfolio companies.
- Notable positions include XCENA, PineTree Therapeutics, BreezeBio.
About STIC Ventures
Founded in 2018, STIC Ventures is the venture capital arm of STIC Investments based in Seoul, South Korea. The firm seeks to invest in B2B, B2C, gaming, media, logistics, healthcare, information technology, gaming, life science, material & resources sectors based in the Asian region.
STIC Ventures portfolio at a glance
63 portfolio companies are on record for STIC Ventures, including XCENA, PineTree Therapeutics and BreezeBio.
12 of the 63 carry a recorded valuation.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Free account
See more of the book
- ·The top 10 names in the book — of 63 recorded positions
- ·Watchlist + alerts for STIC Ventures's activity
Portfolio
63 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| XCENA | — | ▮ | ▮ | ▮ |
| PineTree Therapeutics | — | ▮ | ▮ | ▮ |
| BreezeBio | — | ▮ | ▮ | ▮ |
+ 60 more companies · all 63, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Frequently asked about STIC Ventures
- What companies does STIC Ventures invest in?
- STIC Ventures has 63 recorded portfolio companies, including XCENA, PineTree Therapeutics, BreezeBio.
- What is STIC Ventures's AUM?
- STIC Ventures manages approximately $1.4B in assets.